Skip to main content
Clinical Trials/NCT05815199
NCT05815199RecruitingNot Applicable

Effectiveness and Impact of Counseling Enhanced Using Electronic Cigarettes for Harm Reduction in People With Serious Mental Illness

NYU Langone Health2 sites in 1 country60 target enrollmentStarted: November 13, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
60
Locations
2
Primary Endpoint
Percentage of Participants who Achieve a 100% Reduction in Cigarettes Per Day (CPD) by Week 4

Study Overview

Brief Summary

In this open-label, randomized controlled trial study, participants who smoke combustible cigarettes (CC) and are diagnosed with Serious Mental Illness (SMI) will be randomized in two arms to receive harm-reduction counseling and Ecological Momentary Intervention text messaging (EMI) along with either e-cigarettes (EC) or nicotine replacement therapy (NRT) such as patch and lozenges to compare the efficacy in CC smoking reduction.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
21 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Currently smokes 5 or more CPD
  • Willingness and ability to provide informed consent
  • Age of at least 21 years
  • Has SMI diagnosis (such as Schizophrenia, Schizoaffective disorders, Bipolar disorder, Depressive disorders, Trauma and stressor related disorders etc.) as determined using the MINI tool
  • Interested in reducing CC smoking but not necessarily trying to quit
  • Own a mobile phone or have regular access to a mobile phone
  • Able to provide an additional contact to improve follow-up rates

Exclusion Criteria

  • Is pregnant or breastfeeding
  • Used tobacco other than CC in the past 2 weeks (e.g., EC, cigarillo)
  • Currently engaged in an attempt to quit CC
  • Change in dose of their psychotropic medication(s) in the last 30 days
  • Meeting DSM-V criteria for current alcohol or substance use disorder except for nicotine use disorder and active mild alcohol or substance use disorders.
  • Past month suicidal ideation/suicide attempt and/or psychiatric hospitalization in the last 30 days

Outcomes

Primary Outcomes

Percentage of Participants who Achieve a 100% Reduction in Cigarettes Per Day (CPD) by Week 4

Time Frame: Up to Week 4

Measured via self-report (daily diary about smoking behavior) and verified by exhaled carbon-monoxide (eCO) level (\< 6 ppm).

Percentage of Participants who Achieve a 100% Reduction in Cigarettes Per Day (CPD) by Week 8

Time Frame: Up to Week 8

Measured via self-report (daily diary about smoking behavior) and verified by exhaled carbon-monoxide (eCO) level (\< 6 ppm).

Secondary Outcomes

  • Self-Reported Percent Change in CPD from Baseline to Week 12(Baseline, Week 12)
  • Percentage of Participants who Achieve a 100% Reduction in Cigarettes Per Day (CPD) by Week 12(Up to Week 12)
  • Self-Reported Percent Change in CPD from Baseline to Week 8(Baseline, Week 8)
  • Change in American Thoracic Questionnaire Score from Baseline to Week 12(Baseline, Week 12)
  • Change in Symptom Check Questionnaire Score from Baseline to Week 12(Baseline, Week 12)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (2)

Loading locations...

Similar Trials